181 related articles for article (PubMed ID: 25897353)
1. Endothelial and platelet markers in diabetes mellitus type 2.
Kubisz P; Stančiaková L; Staško J; Galajda P; Mokáň M
World J Diabetes; 2015 Apr; 6(3):423-31. PubMed ID: 25897353
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus: a hypercoagulable state.
Carr ME
J Diabetes Complications; 2001; 15(1):44-54. PubMed ID: 11259926
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis and available prevention options in patients with diabetic thrombophilia.
Kwiatkowski J; Halupczok-Żyła J; Bolanowski M; Kuliszkiewicz-Janus M
Adv Clin Exp Med; 2018 Oct; 27(10):1447-1452. PubMed ID: 30062868
[TBL] [Abstract][Full Text] [Related]
4. Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation.
Yngen M; Östenson CG; Hu H; Li N; Hjemdahl P; Wallén NH
Diabetologia; 2004 Mar; 47(3):537-540. PubMed ID: 14963650
[TBL] [Abstract][Full Text] [Related]
5. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus.
Morel O; Hugel B; Jesel L; Lanza F; Douchet MP; Zupan M; Chauvin M; Cazenave JP; Freyssinet JM; Toti F
Thromb Haemost; 2004 Feb; 91(2):345-53. PubMed ID: 14961163
[TBL] [Abstract][Full Text] [Related]
6. Platelet dysfunction in type 2 diabetes.
Vinik AI; Erbas T; Park TS; Nolan R; Pittenger GL
Diabetes Care; 2001 Aug; 24(8):1476-85. PubMed ID: 11473089
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor in diabetic angiopathy.
Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
[TBL] [Abstract][Full Text] [Related]
8. Immunophilins are involved in the altered platelet aggregation observed in patients with type 2 diabetes mellitus.
López E; Berna-Erro A; Hernández-Cruz JM; Salido GM; Redondo PC; Rosado JA
Curr Med Chem; 2013; 20(14):1912-21. PubMed ID: 23432586
[TBL] [Abstract][Full Text] [Related]
9. Soluble endothelial protein C receptor and high sensitivity C reactive protein levels as markers of endothelial dysfunction in patients with type 1 and type 2 diabetes mellitus: their role in the prediction of vascular complications.
Zaghloul A; Al-Bukhari TA; Al-Pakistani HA; Shalaby M; Halawani SH; Bajuaifer N; Teama SH
Diabetes Res Clin Pract; 2014 Dec; 106(3):597-604. PubMed ID: 25312870
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.
Colwell JA
Am J Cardiovasc Drugs; 2004; 4(2):87-106. PubMed ID: 15049721
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus.
Zhou AM; Xiang YJ; Liu EQ; Cai CH; Wu YH; Yang LB; Zeng CL
BMC Cardiovasc Disord; 2020 Jan; 20(1):15. PubMed ID: 31931718
[TBL] [Abstract][Full Text] [Related]
12. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
Blann AD; Lip GY
Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464
[TBL] [Abstract][Full Text] [Related]
13. Platelet mitochondrial dysfunction of DM rats and DM patients.
Wu F; Liu Y; Luo L; Lu Y; Yew DT; Xu J; Guo K
Int J Clin Exp Med; 2015; 8(5):6937-46. PubMed ID: 26221230
[TBL] [Abstract][Full Text] [Related]
14. Rac1 Modulates Endothelial Function and Platelet Aggregation in Diabetes Mellitus.
Schiattarella GG; Carrizzo A; Ilardi F; Damato A; Ambrosio M; Madonna M; Trimarco V; Marino M; De Angelis E; Settembrini S; Perrino C; Trimarco B; Esposito G; Vecchione C
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29626150
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.
Luo M; Li R; Deng X; Ren M; Chen N; Zeng M; Yan K; Xia J; Liu F; Ma W; Yang Y; Wan Q; Wu J
Acta Diabetol; 2015 Oct; 52(5):943-9. PubMed ID: 25820527
[TBL] [Abstract][Full Text] [Related]
16. Glucose metabolism in lean patients with mild type 2 diabetes mellitus: evidence for insulin-sensitive and insulin-resistant variants.
García-Estévez DA; Araújo-Vilar D; Saavedra-González A; Fiestras-Janeiro G; Cabezas-Cerrato J
Metabolism; 2002 Aug; 51(8):1047-52. PubMed ID: 12145780
[TBL] [Abstract][Full Text] [Related]
17. Platelet Microparticles Mediate Glomerular Endothelial Injury in Early Diabetic Nephropathy.
Zhang Y; Ma KL; Gong YX; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Lu CC; Ruan XZ; Liu BC
J Am Soc Nephrol; 2018 Nov; 29(11):2671-2695. PubMed ID: 30341150
[TBL] [Abstract][Full Text] [Related]
18. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
[TBL] [Abstract][Full Text] [Related]
19. Coagulation and oxidative stress plasmatic levels in a type 2 diabetes population.
Barillari G; Fabbro E; Pasca S; Bigotto E
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):290-6. PubMed ID: 19318924
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction and pathogenesis of diabetic angiopathy.
Stehouwer CD; Lambert J; Donker AJ; van Hinsbergh VW
Cardiovasc Res; 1997 Apr; 34(1):55-68. PubMed ID: 9217873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
